Who Paid My Doc
Mohammad Khalifeh
Dentist, Orofacial Pain Los Angeles, CA Doctor of Dentistry
NPI 1417045931 CMS profile 545662
5757 Wilshire Blvd.,, Suite # 5, Los Angeles, CA 90036
General payments
$258
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Mohammad Khalifeh of Los Angeles, CA is reported in the CMS Open Payments database as having received $258 across 12 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 60th percentile of Dentist, Orofacial Pain profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $22 | 1 | |
| 2023 | General | $76 | 4 | |
| 2022 | General | $22 | 1 | |
| 2021 | General | $20 | 1 | |
| 2019 | General | $118 | 5 |
Beside peers
- Mohammad Khalifeh
- Dentist, Orofacial Pain median
- Middle half of Dentist, Orofacial Pain
- National median
In program year 2025, general payments to Mohammad Khalifeh were reported at $22. Among 51 Dentist, Orofacial Pain profiles paid that year, the median was $95 and the middle half received between $23 and $171.
Show as a table
| Year | Mohammad Khalifeh | Dentist, Orofacial Pain median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $118 | $102 | $46–$213 | $163 |
| 2020 | $0 | $62 | $16–$136 | $114 |
| 2021 | $20 | $120 | $32–$293 | $132 |
| 2022 | $22 | $161 | $70–$404 | $149 |
| 2023 | $76 | $76 | $28–$200 | $160 |
| 2024 | $0 | $71 | $26–$196 | $164 |
| 2025 | $22 | $95 | $23–$171 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 3 drugsPart D claims
47
Drug cost
$187
Branded share of claims
44.7%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Chlorhexidine Gluconate | Generic | 13 | $96 | |
| Amoxicillin | Generic | 13 | $58 | |
| Sodium Fluoride Sensitive Sodium Fluoride/Potassium Nit | Brand | 21 | $33 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.
Records
12 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Dentist, Orofacial Pain in California
Brigitte Lovell
Dentist, Orofacial Pain · Ojai, CA
Ali Makki
Dentist, Orofacial Pain · Irvine, CA
Rich Hirschinger
Dentist, Orofacial Pain · Beverly Hills, CA
Katayoun Omrani
Dentist, Orofacial Pain · Los Angeles, CA
Victoria Wexley
Dentist, Orofacial Pain · Los Angeles, CA
Rashpal Deol
Dentist, Orofacial Pain · San Ramon, CA
Related records
Dentist, Orofacial Pain in California
Practitioners in the same specialty and state, ranked by reported value.
All Dentist, Orofacial Pain
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.